首页> 外文期刊>Hepatitis Monthly >RISK FACTORS OF HCV SEROCONVERSION IN HEMODIALYSIS PATIENTS IN TABRIZ, IRAN
【24h】

RISK FACTORS OF HCV SEROCONVERSION IN HEMODIALYSIS PATIENTS IN TABRIZ, IRAN

机译:伊朗塔布利兹血液透析患者丙型肝炎病毒血清转化的危险因素

获取原文
       

摘要

Background: Hepatitis C virus (HCV) infection is a significant health concern in patients with end-stage renal disease under dialysis. Epidemiological studies have reported a prevalence rate of 5.5-55.9% for this condition in Iran.Objectives: We evaluated the risk factors for HCV infection and seroconversion in hemodialysis patients.Patients and Methods: A retrospective analysis was performed on 455 hemodialysis patients from each of the five dialysis units in Tabriz, northwest Iran. Possible risk factors for HCV infection and seroconversion were evaluated.Results: A total of 37 patients were HCV positive (8.1% of the study population) and seroconversion occurred in 18 of them during the dialysis treatment (3.95% of the study population). History of renal transplantation (44.4%, PConclusions: The current study indicates increased risk for HCV infection in patients under dialysis and its relation with the mean duration of hemodialysis, history of renal transplantation and surgical intervention. Considering the immune deficiency in these patients, intense education to both patients and medical staff will be beneficial.
机译:背景:丙型肝炎病毒(HCV)感染是透析终末期肾脏疾病患者的重要健康问题。流行病学研究报告称,伊朗这种情况的患病率为5.5-55.9%。目的:我们评估了血液透析患者HCV感染和血清转化的危险因素。伊朗西北大不里士的五个透析部门。结果:共有37例HCV阳性(占研究人群的8.1%),并且在透析治疗期间有18例发生了血清转化(占研究人群的3.95%),评估了HCV感染和血清转化的可能危险因素。肾移植史(44.4%,PConclusions:当前研究表明透析患者中​​HCV感染的风险增加以及与平均血液透析时间,肾移植史和手术干预的关系。考虑到这些患者的免疫缺陷,强烈对患者和医护人员的教育将是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号